BCL2 and prostate carcinoma: To further elucidate the mechanism of ZQD in inhibiting prostate cancer and unveil the role of miR-143 in mediating the effects of ZQD, we performed bioinformatics analysis using Targetscan, which suggested a direct binding site between miR-143 and the 3’-UTR of Bcl-2 (Figure 5A).